What are the typical presentation, supportive management, and warning signs for hand, foot and mouth disease (HFMD) in a child under five years old?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hand, Foot, and Mouth Disease in Children Under Five

Typical Clinical Presentation

HFMD typically begins with fever (often the first symptom), followed 1-2 days later by painful oral lesions and a characteristic vesicular rash on the hands, feet, and sometimes buttocks. 1

Initial Symptoms (Days 1-2)

  • Fever is usually the first manifestation, typically low-grade but can exceed 102.2°F (39°C) 1
  • General malaise, irritability, and discomfort are common early signs 1
  • Respiratory symptoms such as cough and rhinitis may occur, especially in younger children 1

Rash Development (Days 2-3)

  • Oral lesions develop first, appearing as small red spots that progress to painful vesicles and ulcers on the tongue, gums, and inside of the cheeks 1
  • Vesiculopapular rash on hands and feet (including palms and soles) is the most common clinical characteristic 2
  • Buttocks may also be involved 3

Disease Course

  • Fever usually subsides within 3-4 days 1
  • Oral ulcers may persist for 7-10 days and cause significant discomfort leading to decreased oral intake 1
  • The illness is typically self-limiting and resolves without complications 4, 2

Supportive Management

Treatment focuses on symptom relief with oral analgesics, maintaining hydration, and intensive skin care, as there is no specific antiviral therapy available. 5, 4

Pain and Fever Control

  • Use acetaminophen or NSAIDs for a limited duration to relieve pain and reduce fever 5
  • Avoid aspirin in children due to Reye's syndrome risk (general medical knowledge)

Oral Lesion Management

  • Apply white soft paraffin ointment to the lips every 2 hours to prevent drying and cracking 5
  • Use mild toothpaste and gentle oral hygiene 5
  • Clean the mouth daily with warm saline mouthwashes 5
  • Apply benzydamine hydrochloride oral rinse or spray every 3 hours, particularly before eating, to reduce inflammation and pain 5
  • For severe oral involvement, consider betamethasone sodium phosphate mouthwash (0.5 mg dissolved in 10 mL water) as a 2-3 minute rinse-and-spit solution one to four times daily 5
  • Barrier preparations such as Gengigel mouth rinse or gel may help with pain control 5

Dietary Modifications

  • Eliminate tomatoes, citrus fruits, hot drinks, and spicy, hot, raw, or crusty foods that exacerbate oral pain 5
  • Drink ample fluids to keep the mouth moist and prevent dehydration 5
  • Monitor closely for signs of dehydration, particularly in children refusing oral intake due to painful mouth sores 1

Skin Care

  • Apply intensive moisturizing creams to hands and feet, particularly urea-containing products 5
  • Avoid friction and heat exposure to affected areas 5
  • For itchiness, zinc oxide can be applied as a protective barrier after gentle cleansing 5
  • Apply zinc oxide in a thin layer; for nighttime relief, consider loose cotton gloves to create an occlusive barrier 5
  • Avoid applying zinc oxide to open or weeping lesions 5

Foot Lesion Care (if open sores present)

  • Wash feet daily with careful drying, particularly between the toes 5
  • Avoid walking barefoot and wear appropriate cushioned footwear 5
  • Do not soak feet in footbaths, as this can induce skin maceration and worsen open sores 5
  • Monitor for signs of secondary bacterial infection (increased redness, warmth, purulent drainage, or worsening pain) 5

Infection Control

  • Hand hygiene with thorough handwashing using soap and water is the most important preventive measure (more effective than alcohol-based sanitizers) 5
  • Clean toys and objects that may be placed in children's mouths 5
  • Avoid sharing utensils, cups, or food 5

Return to Daycare

  • Children can return to daycare once fever has resolved and mouth sores have healed, even if skin rash is still present 5
  • Exclusion based solely on healing skin lesions is not necessary 5

Warning Signs Requiring Immediate Medical Attention

Parents must be counseled to seek immediate medical care if any neurological or respiratory warning signs develop, as these indicate potentially life-threatening complications. 1

Critical Red Flags

  • Persistent high fever despite antipyretics 1
  • Lethargy or unusual drowsiness 1
  • Severe headache 1
  • Stiff neck (meningismus) 1
  • Unusual irritability or altered mental status 1
  • Respiratory distress (may indicate rare but serious complications like neurogenic pulmonary edema) 1

Serious Complications to Monitor For

  • Neurological complications including meningitis, encephalitis, and acute flaccid paralysis can occur, particularly with Enterovirus 71 infections 1, 6
  • Brain stem encephalitis (rhomboencephalitis) is a rare but severe complication associated with EV-A71 6
  • Cardiopulmonary complications, though rare, can be fatal 4

Follow-Up Considerations

  • Reassess after 2 weeks if lesions are not improving with standard care 5
  • Re-evaluate after 4 weeks if evidence of infection has not resolved and consider alternative diagnoses 5
  • Nail changes (Beau's lines or periungual desquamation) may appear 1-2 months after fever onset as a delayed sequela, not active disease 5
  • Onychomadesis (nail shedding) can occur 1-2 months post-infection, particularly with Coxsackievirus A6 6

Important Clinical Pearls

  • Distinguish HFMD from herpes simplex virus infection, as HSV has available antiviral treatment whereas HFMD does not 5
  • Consider Kawasaki disease in the differential diagnosis due to its potential for cardiac complications; Kawasaki presents with persistent high fever, diffuse erythema (not vesicular lesions), conjunctival injection, strawberry tongue, and cervical lymphadenopathy 1
  • Coxsackievirus A6 causes more severe and atypical presentations with widespread exanthema beyond classic distribution 6, 7
  • Immunocompromised patients may experience more severe disease and should be monitored closely 5
  • The disease is highly contagious; by the time HFMD is diagnosed, the child has likely had the infection for weeks 5

References

Guideline

Hand, Foot, and Mouth Disease Clinical Presentation and Progression

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Managing hand-foot-mouth disease in children: More of counseling, less of medicines.

Journal of family medicine and primary care, 2024

Research

Current status of hand-foot-and-mouth disease.

Journal of biomedical science, 2023

Guideline

Diagnosis and Management of Hand, Foot, and Mouth Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Hand, Foot, and Mouth Disease Causative Agents and Clinical Significance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Is the hand, foot, and mouth (HFMD) rash concurrent with the recovery phase of the illness?
What is the management for hand, foot, and mouth disease?
What is the treatment for hand, foot, and mouth disease?
What is the treatment for Hand, Foot, and Mouth Disease (HFMD)?
What is the management approach for Hand, Foot, and Mouth Disease (HFMD)?
What are the possible causes of migrating arthralgia and what initial evaluation should be performed?
For a healthy adult without renal impairment, pregnancy, or bismuth allergy, what is the recommended dosing, indications, contraindications, adverse effects, and monitoring for colloidal bismuth sulphate?
How do I diagnose hypertensive cardiovascular disease (including criteria and work‑up algorithm), what is the recommended treatment, and when and how should I initiate clopidogrel (including loading dose, duration, and use in dual antiplatelet therapy after percutaneous coronary intervention) for my patient?
How does retatrutide compare to tirzepatide regarding efficacy, safety profile, and overall effects for treating obesity (with or without type 2 diabetes)?
Can empagliflozin be prescribed to a 71‑year‑old patient with coronary artery disease who underwent percutaneous coronary intervention, has a normal left ventricular ejection fraction, and an NT‑proBNP of 9000 pg/mL?
How should I manage a Salmonella infection identified in bone‑marrow cultures, including antibiotic choice, duration, monitoring, and indications for surgical intervention?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.